Besides, as compared with the Linc00284 knockdown group, miR-27a inhibitor treatment was able to reverse the reduced proliferative capacity of CRC cells caused by Linc00284 knockdown (Fig. 5H, I). The gene discussed is NRAD1; the disease is colorectal carcinoma.